baber/WOPTO huggingface dataset:
Patent ES-2313888-T3 (ES)
Inventor: RUDE GREGORY J
IPC: A63G7/00
Filed: 2000-04-05
Granted: 2009-03-16
Abstract: A dueling or racing roller coaster ride has tracks which approach or cross over each other at near miss locations. A controller system controls the timing of launch of a roller coaster vehicle on each track to better achieve consistent simultaneous arrival of the roller coaster vehicles at the near miss locations, to provide increased thrills and excitement to the riders. The control system determines the loaded vehicle weight via current draw on the track side vehicle motors. The control system generates a vehicle performance parameter, based on past vehicle speed over the track, to compensate for roller resistance and aerodynamic factors. The vehicle weight information and performance parameters are used to determine which vehicle to launch first, and the amount of delay between launching the vehicle on the first track and launching the vehicle on the second track, to better achieve simultaneous arrival at one or more locations.
Patent ES-2202116-T3 (ES)
Inventor: FONTANILLE DANIEL
IPC: B02C17/18
Filed: 2000-05-04
Granted: 2004-04-01
Abstract: The ball mill is of the type including:a rotary drum (11, 12, 13) having a horizontal axis (XX') and each end of which is supported by a journal (14, 15) which terminates it and through which passes an axial tube (41) around which it delimits an annular duct (35), a vertical pipe (6) discharging in the vicinity of the journal at the level of a guide member (31) for directing material to be pulverized from the pipe towards the drum, and an outlet duct (36) communicating with the annular duct for ejecting from the drum the mixture consisting of the gas and the pulverized material. Each journal contains a rigid helicoidal Archimedes screw structure (32) fixed to it and turning with it about the tube, when the drum rotates, which tube is a rigid immobile gas injector tube.
Patent ES-2233393-T3 (ES)
Inventor: CORVI MORA PAOLO
IPC: A61K8/00
Filed: 2000-04-19
Granted: 2005-06-16
Abstract: Salts of asiatic and madecassic acid with pharmaceutically acceptable organic bases, suitable for the preparation of pharmaceutical and cosmetic compositions for the topical and systemic treatment of erithema, varicose ulcers, venous insufficiency, bedsores, delayed cicatrization, ambustions, traumatic and surgery wounds, alloeosises of the cutaneous trophism, ophthalmic alloeosises and inflammatory processes.
Patent ES-2215678-T3 (ES)
Inventor: FRANKS NICHOLAS PETER
IPC: A61K9/08
Filed: 2000-06-09
Granted: 2004-10-16
Abstract: A pharmaceutical composition is described. The composition comprises a formulation. The formulation comprises an NMDA antagonist and an alpha-2 adrenergic agonist. In a preferred aspect, there is provided an improved anaesthetic comprising an NMDA antagonist and an alpha-2 adrenergic agonist.
Patent ES-2195910-T3 (ES)
Title: Dispositivo para plegar solapas de envases de tipo caja.
Inventor: GAUDENZI RODOLFO
IPC: B65B7/20
Filed: 2000-07-19
Granted: 2003-12-16
Abstract: La presente invención se refiere a máquinas automáticas de embalaje. En particular, la presente invención trata sobre un dispositivo, que está unido a una máquina para embalar productos en envases afines de tipo caja, y que es capaz de plegar solapas verticales de los envases durante las etapas de cierre de dichos envases.
Patent ES-2252048-T3 (ES)
Inventor: ANDERSEN TINA MEINERTZ
IPC: A61K47/42
Filed: 2000-09-11
Granted: 2006-05-16
Abstract: A solid composition containing a meiosis activating substance can be prepared by adding a protein or a phosperglycid.
Patent ES-2235980-T3 (ES)
Inventor: WILKE HANS JOACHIM
IPC: A47C31/12
Filed: 2000-10-25
Granted: 2005-07-16
Abstract: A reclining device ( 1 ) is described having a support ( 10 ) which can be moved back and forth between different positions automatically and continuously, so that the spinal column and other joints, for example of the hip, knee, leg, can be moved and exercised specifically.
Patent ES-2258482-T3 (ES)
Inventor: DOMB ABRAHAM J
IPC: A61L31/10
Filed: 2000-11-30
Granted: 2006-09-01
Abstract: The invention provides an electropolymerizable monomer comprising a chemically bound active agent, said agent being capable of affecting animal tissue.
Patent ES-2237482-T3 (ES)
Inventor: COATS STEVEN J
IPC: A61P5/34
Filed: 2000-12-21
Granted: 2005-08-01
Abstract: The present invention is directed to a series of novel substituted aminoalkylamide derivatives, pharmaceutical compositions containing them and their use in the treatment of reproductive disorders and affective conditions. Further, the compounds of the invention are antagonists of follicle stimulating hormone, a hormone associated with the human reproductive system.
Patent ES-2383486-T3 (ES)
Inventor: HOEHNE WOLFRAM
IPC: B60J7/06
Filed: 2001-01-08
Granted: 2012-06-21
Abstract: The awning cover has spaced hoops (5) attached to movable carriages used for supporting the awning sheet, with setting elements between the spaced hoops. Each carriage has attached rollers (8,9) for movement along a rail (10), with interlocking projections (15) at both ends of each carriage positioned above and below the rail in alternation.
Patent ES-2254266-T3 (ES)
Title: Proceso para el recubrimiento por pulverizacion dentro de una camara de recubrimiento por pulverizacion.
Inventor: MAY THOMAS
IPC: C11D7/32
Filed: 2001-01-15
Granted: 2006-06-16
Abstract: Medio de enjuague no acuoso que está destinado a ser usado para enjuagar un equipo de recubrimiento, constando dicho medio de enjuague de: (a) un 20 a un 35% en peso de al menos una N- alquilpirrolidona; (b) un 20 a un 35% en peso de un acetato seleccionado de entre los miembros del grupo que consta de acetato de butilo, acetato de isobutilo y mezclas de los mismos; (c) un 10 a un 20% en peso de al menos un éter glicólico completamente miscible con agua; (d) un 5 a un 15% en peso de un alcohol seleccionado de entre los miembros del grupo que consta de etanol, propanol, isopropanol y mezclas de los mismos; (e) un 10 a un 20% en peso de al menos una cetona alifática que tiene de 4 a 7 átomos de carbono; (f) un 0 a un 5% en peso de al menos un disolvente orgánico de los que son usados convencionalmente en los agentes de recubrimiento; y (g) un 0 a un 5% en peso de al menos un agente auxiliar; estando la suma de los componentes de la parte (a), la parte (c) y la parte (d) situada entre un 40% yun 60% en peso, sobre la base del peso de la totalidad del medio de enjuague.
Patent ES-2291237-T3 (ES)
Inventor: HILBIG KLAUS
IPC: B31F1/07
Filed: 2001-02-16
Granted: 2008-03-01
Abstract: The present invention relates to a paper tissue, and in particular to facial tissue, and disposable handkerchiefs. Claimed and described is a method for making a tissue paper product from a tissue paper web, the method comprising the steps of:   passing said tissue paper web through an embossing nip formed between a first and a second embossing roll, wherein at least one of said embossing rolls comprises at least 30 embossing elements per square centimetre. applying a transferable lotion to at least portions of said tissue paper web   Further claimed are paper tissue products made in accordance with the above method.
Patent ES-2238355-T3 (ES)
Title: Dispositivo y procedimiento para la medicion del chasis de un vehiculo.
Inventor: GRANATA TEBALDO
IPC: G01B21/26
Filed: 2001-04-19
Granted: 2005-09-01
Abstract: Dispositivo de medición de chasis para vehículos, en especial para vehículos de motor, que comprende una plataforma elevadora de vehículos (20), con la que se puede elevar de forma reversible un vehículo que se ha de medir, y un dispositivo elevador para medición de ejes (30), con el que se puede elevar de forma reversible una unidad de medición de ejes (60), caracterizado por el hecho de que el dispositivo elevador para medición de ejes (30) presenta como mínimo dos niveles de elevación (40, 50), dispuestos uno sobre otro y desplazables verticalmente, los cuales se pueden controlar de forma reversible independientemente el uno del otro, y de que la unidad de medición de ejes (60) se halla dispuesta en el primer nivel de elevación (40), situado encima.
Patent ES-2250274-T3 (ES)
Inventor: STANDKE BURKHARD DR
IPC: C04B41/49
Filed: 2001-08-07
Granted: 2006-04-16
Abstract: An organosiloxane chosen from (i) organosiloxane that carries triamino group(s), Si-C bonded fluoroalkyl group(s), hydroxyl and/or alkoxy group(s); (ii) a formulation of organosiloxane(s) as per (i); (iii) an alkylalkoxysilane; and/or (iv) a formulation of organosiloxane(s) which carries amino group(s), Si-C bonded 1-16C alkyl group(s), hydroxyl and/or alkoxy group(s), is applied to a substrate. A composition comprising an organosiloxane is first applied onto a substrate. The organosiloxane is selected from: (i) an organosiloxane which carries triamino group(s) of formula (NHx(CH2)aNHy(CH2)bNHz)- (I) (attached through N-bonded 1-4C alkylene group(s) to silicon atom(s)), Si-C bonded fluoroalkyl group(s) of formula F3C(CF2)r(CH2)s-, and hydroxyl and/or alkoxy group(s) (ii) a formulation comprising an organosiloxane or a mixture of organosiloxanes as per (i); (iii) an alkylalkoxysilane in which alkyl represents 1-16C alkyl radicals and alkoxy represents methoxy, ethoxy, propoxy or butoxy; and/or (iv) a formulation comprising organosiloxane(s) which carries amino group(s) of formula (NH2(CH2)a(NH)r(CH2)b(NH)s)- (II)(attached through N-bonded 1-4C alkylene group(s) to silicon atom(s)), Si-C bonded 1-16C alkyl group(s), and hydroxyl and/or alkoxy group(s). In (I): a and b = 1-6; x = 0-2; y = 0 or 1; z = 0-2; r = 0-18; s = 0 or 2; (x+y+z) = ≤ 4; In (II): a and b = 0-6; y = 0 or 1; s = 0 or 1, subject to the proviso that when a=0, then r=0 and when b=0, then s=0. Then, a coating of an organosiloxane as per (i) or an organosiloxane containing composition as per (ii), is applied to the treated substrate. Independent claims are also included for: (i) coating; (ii) production of an absorbent inorganic substrate repellent for ink, paint, pollutant, bioorganism, oil, water and/or dirt which involves forming the coating on inorganic substrate; and (iii) coated substrate.
Patent ES-2252122-T3 (ES)
Inventor: RAUEISEN REINHARD
IPC: B31B50/25
Filed: 2001-08-16
Granted: 2006-05-16
Abstract: The adjuster and/or fixer are fixed relative the toolholder for the pre-slit rolls (23,25) by means of permanent magnets here for use in an envelope machine. The magnets and a control element serve a row of suction holes round the circumference of the pre-slitter (28,29) rolls (23,25), with the suction hole row acting as holder and the pre-slit rolls as toolholders. The control element and magnets thus set and fix the positions and the hole row or other roll (23 or 25) has an adjustable holder (31). Magnets and suction holes are placed on different roll radii. The magnets stand like poles facing one another or vice versa and the group of magnets can be replaced by a single magnet.
Patent ES-2292518-T3 (ES)
Inventor: ITO KATSUYA
IPC: B29D7/01
Filed: 2001-10-19
Granted: 2008-03-16
Abstract: The present invention relates to a heat shrinkable polyester film. The present invention also relates to a heat shrinkable polyester tube obtained from the heat shrinkable polyester film, a production method thereof, a label using this tube and a container wearing this label. The heat shrinkable polyester film of the present invention has suitable heat shrinkable properties, superior printing property and adhesion property with a solvent. When it is used for packaging (e.g., covering, bundling and the like), the film shows superior appearance and good mountability. Moreover, the heat shrinkable polyester film of the present invention has a small apparent specific gravity and is easily collected separately from a bottle when it is used as a label of a bottle (such as PET bottle).
Patent ES-2217107-T3 (ES)
Inventor: KELLER RICO
IPC: H04W4/029
Filed: 2001-02-23
Granted: 2004-11-01
Abstract: The method involves determining the geographic positions of mobile users' communications terminals (1) and storing them in a central unit (3). At least one future or anticipated geographic position for a given mobile user is determined from stored positions for the user and associated information is selected and transmitted to the user. Independent claims are also included for the following:- a system for transmitting location-specific information to mobile users in mobile radio network.
Patent ES-2236194-T3 (ES)
Title: Derivados de amino pirazol utilizados en el tratamiento de la obesidad y de otros transtornos.
Inventor: KORDIK CHERYL P
IPC: C07D231/42
Filed: 2001-02-23
Granted: 2005-07-16
Abstract: Un compuesto de **fórmula** en la que cada R1 y R2 se selecciona independientemente entre el grupo compuesto por hidrógeno, alquilo C1-C6, sulfonilamino, y arilsulfonilo no sustituido o sustituido; siendo los sustituyentes del arilsulfonilo uno o más sustituyentes seleccionados independientemente entre halógeno, alquilo C1-C6, alcoxi C1-C6, trifluorometilo o trifluorometoxi; R3 se selecciona entre el grupo compuesto por arilo no sustituido o sustituido y heteroarilo no sustituido o sustituido; siendo los sustituyentes del arilo o heteroarilo uno o más sustituyentes seleccionados independientemente entre halógeno, alquilo C1-C6, alcoxi C1- C6, trifluorometilo, trifluorometoxi, amino, alquilamino C1- C6 o di(alquil C1-C6)amino; L se selecciona entre el grupo compuesto por arilo no sustituido o sustituido, heteroarilo no sustituido o sustituido y cicloalquilo C3-C8; siendo los sustituyentes del arilo o heteroarilo uno o más sustituyentes seleccionados independientemente entre halógeno, alquilo C1- C4 o trifluorometilo; n es un entero seleccionado entre 0 o 1; X se selecciona entre el grupo compuesto por sulfonilamino, aminocarbonilo, carbonilo, carbonilamino, sulfonilo, sulfonilaminoalquilo C1-C6, alquil C1-C6- aminosulfonilo, y di(arilsulfonilo no sustituido o sustituido)-amino; siendo los sustituyentes del grupo arilo uno o más sustituyentes seleccionados independientemente entre halógeno, alquilo C1-C6, alcoxi C1-C6, trifluorometilo, trifluorometoxi, alquil C1-C6- carbonilamino, amino, alquilamino C1-C6 o di(alquil C1- C6)amino, y donde los dos grupos arilo del di(arilsulfonilo no sustituido o sustituido)amino tienen el mismo patrón de sustitución.
Patent ES-2261384-T3 (ES)
Inventor: RITTERHOFF JURGEN
IPC: H01M8/00
Filed: 2001-01-20
Granted: 2006-11-16
Abstract: A torque motor, especially a fuel cell torque motor, converts chemically stored energy of liquid or gaseous fuels, directly inside the torque motor while avoiding a separate installation of devices, into mechanical energy for driving at least one consumer. The torque motor is provided with fuel cells that serve as an internal energy source, the fuel cells being arranged in the stator around the rotational axis of the motor in an annular manner. The torque motor includes a rotor and stator with permanent magnets arranged on the rotor and with armature windings located in the stator. The armature windings are supplied with current from a commutator having electronic power components. Fuel cell modules and fuel cell supply and control elements are integrated in the commutator in a structurally modular-like manner. The permanent magnets are arranged with a drum-like or disk-like design on the rotational axis of the fuel cell torque motor, thereby eliminating an external excitation of the electric torque motor in the rotor.
Patent ES-2241811-T3 (ES)
Inventor: RAYBONE DAVID
IPC: F01N3/28
Filed: 2001-04-05
Granted: 2005-11-01
Abstract: A catalytic material for the plasma-assisted treatment of the exhaust gases from internal combustion engines, consisting of an activated alumina, which contains silver or molybdena (MoO<SUB>3</SUB>). For silver doped alumina, a preferred silver concentration is between 0.1% and 5% by weight. The preparation and use of silver doped alumina material also is described.
Patent ES-2267743-T3 (ES)
Inventor: ALEXANDRE PATRICK
IPC: A61M5/303
Filed: 2001-03-27
Granted: 2007-03-16
Abstract: The technical field of the invention is that of pre-filled and disposable needleless syringes, used for intradermal, subcutaneous and intramuscular injections of liquid active principle for therapeutic use in human and veterinary medicine. The inventive syringes ( 1 ) are mainly characterized in that they function with a pyrotechnic charge ( 6 ) consisting of a mixture of powder with high burning rate and a powder with low burning rate. Indeed, the combustion of the powder with a high burning rate enables to communicate instantly, through a piston ( 3 ), a very high speed to the active principle ( 4 ), whereas the combustion of the powder with a low burning rate enables to maintain a threshold pressure level to proceed with the injection, so as to ensure that the active principle ( 4 ) penetrates through the skin. Thus, the injection is properly and homogeneously without any loss of active liquid ( 4 ).
Patent ES-2304384-T3 (ES)
Inventor: REX BRIAN
IPC: F16J15/10
Filed: 2001-06-13
Granted: 2008-10-16
Abstract: A pipe coupling device (2) for joining the ends of two pipes is disclosed. The pipe coupling device (2) includes a sleeve (4) configured to receive an end of a pipe and having an annular first abutment surface (6); a compression member (12) having an annular second abutment surface (10); a sealing and gripping assembly (8) for sealing against and gripping the pipe; and threaded fasteners for drawing the compression member (12) and the sleeve (4) axially together so as to compress the sealing and gripping assembly (8) against the pipe. The sealing and gripping assembly (8) includes a sealing member (14) and a gripping device. The gripping device may include an annular carrier (16) having an annular recess for retaining a gripping member (18). The gripping surface of the gripping member (18) and the annular carrier (16) are adapted for relative axial movement wherein the gripping member (18) may be moved into tighter contact with the pipe.
Patent ES-2311530-T3 (ES)
Inventor: SZILVASSY ZOLTAN
IPC: A61P3/10
Filed: 2001-07-13
Granted: 2009-02-16
Abstract: Pharmaceutical combinations for treatment and/or prevention of all sorts, periods and complications of diabetes mellitus in mammals, thus including the pre-diabetic diseases and their complications, optionally including furthermore ischaemic heart disease comprising an effective dose of at least one enzymatic nitric oxide (NO) donor active ingredient and optionally comprising an effective dose of at least one antidiabetic active ingredient, and further optionally comprising usual pharmaceutically acceptable carriers and/or other auxiliaries. The combination may consist of more than one pharmaceutical compositions. The effective doses related to the new insulin-sensitizing effect are considerably lower than the usual doses related to the know effect of most active substances dues to metabolic effects that influence insulin sensitivity in healthy and insulin resistant mammals. The usual dose of NO-donors is necessary when the patient has also ischaemic heart disease. Preferred antidiabetics include insulin, a thiazolidinedion, a biguanide derivative, an alpha-glucosidase-inhibitor, and alpha2-adrenergic-antagonist and/or a sulphonamide, preferably a sulphonylurea. Preferred enzymatic NO donors are nitroglycerin, racemic isosorbide monoitrate, and/or its stereoisomers, racemic isosorbide dinitrate and/or its stereoisomers, erythityl tetranitrate, pentaerythritol-tetranitrate, methylpropyl-propanediol-dinitrate, propatyl nitrate, trolnitrate, tenitramine and/or nicorandile. The invention includes methods of treatment and processes to prepare the compositions.
Patent ES-2284676-T3 (ES)
Title: Mejora de percepcion aumentada de señales acusticas codificadas.
Inventor: BRUHN STEFAN
IPC: G10L19/02
Filed: 2001-09-07
Granted: 2007-11-16
Abstract: Un método para codificar una señal fuente acústica (x) para producir información codificada para transmisión por un medio de transmisión, que comprende: producir, en respuesta a la señal fuente acústica (x), un señal objetivo (T) que está dividida en cuadros, cada uno de los cuales comprende un primer número (n1) de valores de muestras, producir, en respuesta a la señal fuente acústica (x), una señal codificada primaria (P1) que está destinada a coincidir con la señal objetivo (T), estando la señal codificada primaria (P1) dividida en cuadros, cada uno de los cuales comprende el primer número (n1) de valores de muestras. producir, en respuesta a la señal fuente acústica (x), información codificada (S) a partir de la cual la señal codificada primaria (P1) ha de ser reconstruida (), producir, en respuesta a la señal codificada primaria (P1) y la señal objetivo (T), un espectro (C) de mejora indicativo de lo bien que la señal codificada primaria (P1) coincide con la señal objetivo (T), y producir, en respuesta al espectro (C) de mejora, un espectro de mejora codificado (Cq) que constituye una representación codificada del espectro (C) de mejora, caracterizado porque un cuadro de espectro de mejora del espectro (C) de mejora comprende un segundo número (nC) de coeficientes espectrales, siendo el segundo número (nC) mayor que el prime número (n1), y porque el paso de producir un espectro de mejora realiza una ampliación de un cuadro entrante de señal objetivo para que comprenda el segundo número (nC) de valores de muestras y una ampliación de un cuadro entrante de señal codificada primaria para que comprenda el segundo número (nC) de valores de muestras.
Patent ES-2262682-T3 (ES)
Title: Inyector de implante intraocular ligero.
Inventor: JEANNIN LIONEL
IPC: A61F2/16
Filed: 2001-09-27
Granted: 2006-12-01
Abstract: Dispositivo de inyección de implante intraocular en el ojo de un paciente, el implante comprende una parte óptica ligera y dos ramas hápticas que tiene una primera extremidad empalmada a dicha parte óptica y una segunda extremidad libre, dicho dispositivo comprende una cámara de plegamiento (12) de la parte óptica del implante, un órgano de plegamiento (20), una cánula de inyección (14) del implante plegado en el ojo, dicha cánula desemboca en una primera extremidad de dicha cámara, un canal de conducción (16) desemboca en la segunda extremidad de dicha cámara, y un pistón móvil (40) montado en dicho canal de conducción para empujar dicho implante plegado en la mencionada cánula, el pistón comprende una extremidad cilíndrica (44) para cooperar con dicho implante, dicha extremidad comprende una cara de extremidad (50), sensiblemente ortogonal a la longitud del pistón, dicha cara de extremidad que presenta una abertura (52) que desemboca en la pared lateral de la extremidad del pistón y se extiende sobre una parte solamente del diámetro del pistón, dicho dispositivo se caracteriza en que la extremidad (44) del pistón esta provista de una ranura (54) que se extiende sobre una longitud según la dirección del eje de rotación del pistón, dicha longitud l es tal que, con la longitud de dicha abertura, la longitud total sea al menos igual a aquel de la rama háptica, la dicha ranura comunica con dicha abertura y se extiende además sobre todo el diámetro del pistón para desembocar sus extremidades diametrales (54a, 54b) en la pared externa (40a) de la extremidad del pistón, dicha ranura (54) y la dicha abertura (52) tienen la misma anchura y el mismo plano medio diametral.